Daniel W. Fleming

CFO Daniel W. Fleming sells 40,000 shares (7.4% of holdings) for $9,979,281.93 via 10b5-1 plan; stock up 50.7% in 30 days.

Daniel W. Fleming, CFO of Credo Technology Group, executed 11 separate sales totaling 40,000 shares for $9,979,281.93 on 2026-06-11 at a blended average price of $249.48. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2026-01-12, meaning the sales were scheduled rather than discretionary. This sale reduced his holdings from 541,873 to 501,873 shares, a reduction of 7.4%. The company's fundamentals show strong growth (annual revenue growth of +126.3%) with a current market cap of $47,848,158,935.40, though the P/E of 140.98 reflects a significantly elevated valuation. The stock has demonstrated substantial recent momentum (+50.7% in the past 30 days and +149.3% in the past 90 days), trading at $259.41 as of the current price, only 4.0% below its 52-week high of $270.21. Fleming's prior sales at this ticker show mixed outcomes: two recent April 2026 sales posted positive 30-day returns (+20.2% and +21.0%), while three January sales resulted in negative 30-day and 90-day returns (ranging from -13.0% to -20.5%).

CFO Daniel Fleming sells 7,580 shares at blended $152.63 for $1.2M; prior CRDO sales 5 of 5 well-timed with 90d negative returns.

CFO Fleming conducted two separate sales totaling 7,580 shares for $1,156,951.33 on 2026-04-14, reducing his holdings from 441,258 to 433,678 shares (net change: -1.7%). At current price of $158.93, the stock has risen 4.1% above his blended sale price of $152.63. His prior trades at CRDO show a perfect 5-of-5 pattern where sells preceded negative 90-day returns (ranging -4.1% to -21.4%), indicating consistent forward-looking accuracy at this ticker. His broader cross-ticker track record shows 19 prior open-market sells with a 36.84% well-timed rate and average 90-day return of +36.3%, suggesting above-average sell discipline. The company's 126.3% annual revenue growth, elevated P/E of 86.38, and current stock price 16.0% below its 52-week high provide context for elevated valuations.

CFO Fleming sells 8,562 shares in 3 transactions for $1,144,269.68; retains 446,178 shares post-sale.

Fleming Daniel W., Chief Financial Officer of Credo Technology Group, executed 3 separate sales totaling 8,562 shares for $1,144,269.68 at blended average price $133.65 on 2026-01-07 and 2026-01-08. The CFO retains substantial holdings of 446,178 shares post-transaction, representing a 1.9% reduction from prior holdings. Across his cross-ticker track record, Fleming's 16 prior sells achieved a 25.00% well-timed rate at the 90-day mark; at CRDO specifically, 3 of 5 prior sells were well-timed, though recent October 2025 sales preceded modest gains (30-day +18.7% to +17.4%) before reversing to 90-day declines. The current stock price of $150.42 is 20.5% below the 52-week high of $189.19, having declined 4.8% over 30 days, providing context for evaluating the execution timing of these sales relative to recent price momentum.

CFO Fleming sells 112,580 shares for $15.6M at blended $138.20; stock now -15.3% in 30 days vs +40.9% over 90 days

Daniel W. Fleming, Chief Financial Officer, executed 3 separate sales totaling 112,580 shares for $15,558,279.62 at an average price of $138.20, reducing his stake by 19.7% to 458,678 shares post-transaction. The timing merits scrutiny: while the stock is trading at $138.83 (near the transaction price), it has declined 15.3% over the past 30 days despite a strong 40.9% gain over 90 days, and trades 19.4% below its 52-week high of $172.31. Notably, Fleming's prior 4 measurable same-ticker sales at CRDO (March, June, June, and June 2025) were not well-timed at the 90-day mark—all showed positive 90-day returns, meaning the stock rose after each sale. His cross-ticker track record shows an 8.33% well-timed rate across 13 prior sells, suggesting inconsistent predictive accuracy. At a P/E of 192.82 and 90-day uptrend context, this substantial stake reduction by a CFO warrants monitoring for any signal about management's forward confidence in valuation or growth trajectory.

CFO Fleming sells 3.8K CRDO shares at $137.55; stock now at $149.03 (+0.0% from 52-week high, +23.8% in 30 days)

Daniel W. Fleming, CFO of Credo Technology Group, sold 3,790 shares at $137.55 on 2025-09-05, reducing his holdings by 0.7% to 576,178 shares. The sale occurred when CRDO was trading near its 52-week peak of $149.03, with the stock having surged +23.8% over the preceding 30 days and +108.0% over 90 days. Across all open-market sales in Fleming's cross-ticker track record, his average 90-day return was +60.5%, but his 90-day well-timed rate stands at 8.33%—indicating the stock typically rose after his sales. At CRDO specifically, Fleming has sold 5 prior times with mixed near-term results (+21.0% to +27.9% in 30 days on his June trades, but -22.2% to -23.0% on March trades), yet none were well-timed at the 90-day mark (meaning the stock continued upward after each sale). With the company posting +126.3% annual revenue growth, $223.1M latest-quarter revenue, and a P/E of 206.99, the stock remains elevated relative to traditional earnings metrics, and this sale—coinciding with the stock at its extreme high—warrants observation of whether Fleming views current valuations as stretched relative to fundamentals.

CFO Daniel Fleming sold 16,288 shares in 3 tranches for $1,212,609.89 ($74.45 blended avg) on 2025-06-05/06.

Fleming executed 3 separate sales totaling 16,288 shares for $1,212,609.89 over two trading days at prices ranging from $73.18 to $77.35, reducing his holdings by 2.7% from 606,142 to 589,854 shares. The stock has appreciated 39.9% over the prior 30 days and 64.0% over 90 days, trading at $71.09 currently—16.8% below its 52-week high of $85.50. His prior 5 sells at CRDO all posted positive 90-day returns (highs of +76.7%, +78.6%, +124.5%, +119.2%), with none proving well-timed by the metric of foreseeing a subsequent decline. The company reported $135.0M in quarterly revenue and $29.4M in net income, yet carried negative full-year net income in its most recent fiscal year, despite 4.8% annual revenue growth.

CFO Fleming sells 16,288 shares at avg $42.83; stock down -53.9% from 52-week high and -49.0% in 30 days.

Fleming Daniel W., CFO of Credo Technology Group, executed 2 separate sales totaling 16,288 shares for $697,550.51 at an average price of $42.83 on 2025-03-06. This represents a 2.6% reduction of his 633.6K share pre-transaction holdings. Notably, the sale occurred in a sharply deteriorating price environment: the stock is currently $39.45, down 53.9% from its 52-week high and down 49.0% over the prior 30 days. At his prior CRDO sales (5 trades between May and December 2024), Fleming achieved a 90-day well-timed rate of 1 in 5 (20% vs the cross-ticker baseline of 14.29%), and two of those five prior sales preceded sharp declines that yielded 30-day gains between +27.0% and +38.6%. The CFO's current filing occurs after aggressive recent deterioration, placing the sale after substantial downward momentum rather than ahead of it. The company reported positive recent-quarter net income ($29.4M) but was unprofitable over its most recent full fiscal year, adding uncertainty about earnings durability.

CFO Fleming sold 12,504 shares of CRDO at $48.48 on 2024-12-02 (now $70.69); stock near 52-week high after +74.8% in 30 days.

Daniel W. Fleming (Chief Financial Officer) sold 12,504 shares at $48.48, a transaction that occurred when CRDO was trading well below its current price of $70.69. The sale reduced his holdings by only 1.9%, from 669.0K to 656.5K shares, suggesting a modest reduction rather than substantial liquidation. At his SAME-TICKER HISTORY at CRDO, Fleming's prior 5 trades show mixed timing outcomes: his recent September 2024 sales preceded stock gains of +30.0% and +27.0% over 30 days, while his June and May 2024 sales showed only 6.4% and 27.0% 30-day returns respectively, with the May sale ultimately rising +35.6% over 90 days. The company remains unprofitable (net income $-4.2M in latest quarter; full-year negative) despite modest revenue growth of 4.8% year-over-year, which provides context for the CFO's partial position reduction. Fleming's cross-ticker track record shows only a 25.00% well-timed rate on prior sells across all holdings, indicating his historical sales have not consistently preceded stock declines.

CFO Fleming sells 108.8K shares for $3.4M as CRDO stock down 16.5% from 52-week high

Fleming Daniel W., CFO of Credo Technology Group Holding Ltd, executed 2 separate sales totaling 108.8K shares for $3.4M on 2024-09-30, reducing his holdings by 13.9% to 676.4K shares. The sales occurred at a blended average price of $31.10, but the current market price of $30.43 reflects a -16.5% drawdown from the 52-week high and a -12.8% decline over the prior 30 days, suggesting recent market momentum is negative. Examining his prior 4 same-ticker sales at CRDO, only 1 of 4 achieved positive 90-day outcomes after the sale, indicating a 25% well-timed rate at this specific ticker. The company remains unprofitable (full-year net income $-9.5M against latest quarter revenue of $59.7M) and shows modest annual revenue growth of +4.8%, providing limited fundamental tailwind. The timing of this large CFO sell-off during a steep stock decline merits investor attention, particularly given the mismatch between the CFO's recent transaction outcomes and cross-ticker track record.

CFO Daniel Fleming sells 17,500 CRDO shares at $28.63 for $500,974.25; holds 701,714 post-sale.

Daniel Fleming, CFO of Credo Technology Group, sold 17,500 shares at $28.63 on 2024-06-17 while retaining a substantial position of 701,714 shares post-transaction. The stock has since risen 47.4% over 30 days and 29.0% over 90 days, with the transaction price $28.63 now roughly $0.26 above the current price of $28.37—placing the sale near recent highs within the 52-week range of $13.60–$29.21. Examining his prior CRDO sales, both the 2023-12-08 and 2023-12-11 trades preceded positive subsequent returns (0.2% and 10.1% at 30 days, 28.7% and 23.9% at 90 days), indicating a pattern of selling before rallies rather than before declines. The underlying company shows strong growth (73.0% annual revenue increase) but remains unprofitable on a full-year basis despite recent quarterly profitability of $428,000 on $53.1M revenue. The modest share reduction (2.4% of pre-transaction holdings) does not signal a material change in conviction.